CRISPR Therapeutics (CRSP) Competitor Comparison
We are evaluating the key criteria listed to compare CRISPR Therapeutics (CRSP) against its competitors in the Biotechnology industry.
Market Capitalization
26 / 368Gross Profits
278 / 278Total Revenue
66 / 300EBITDA
316 / 337Free Cashflow
329 / 352Quick Ratio
41 / 357Earnings per Share
251 / 359Dividend yield
0 / 6Total Cash
10 / 358Performance 3 years
149 / 368Performance 5 years
134 / 368Performance 10 years
31 / 368Linearity 3 years
74 / 368Linearity 5 years
9 / 368Linearity 10 years
173 / 368Total Rank
306 / 368Dividend Rank
97 / 368Valuation Rank
167 / 368Piotroski Rank
355 / 368Muliplier Rank
320 / 368Performance 3 years - CRSP ranking 149 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.